
معرفی
Alexandre Meloux is an active researcher at the University of Burgundy's UFR Health Sciences, affiliated with INSERM U1093 CAPS in Dijon, France. His work bridges neurology and cardiology with focus on cerebro-cardiovascular interactions, particularly in stroke and ischemic conditions. Contact information shows ongoing institutional affiliation including direct university email and phone number.
- 2016-2019: Doctorate in Physiology at University of Burgundy
- 2015-2016: Master 2 Research in CardioMetabolic Regulations at Claude Bernard University
- 2014-2015: Pharmacy Internship (Pharmaceutical Innovation)
- 2008-2014: Pharmacy Curriculum
His research centers on neuroplasticity mechanisms, particularly BDNF signaling pathways and growth differentiation factors (GDF-15/GDF-8). Key investigations include physical activity's cerebral benefits, endothelial BDNF deletion impacts, and biomarker correlations in stroke and cardiac events. Current work examines electrical muscle stimulation effects on cerebral function and GDF-15's role in neurological deficits post-stroke.
Analysis of his 15 most recent publications (2020-2024) reveals consistent focus on cerebro-cardiac cross-talk, with strong emphasis on molecular biomarkers (BDNF, GDF-15, myostatin) in stroke pathophysiology. Articles predominantly appear in high-impact journals like Stroke (IF 7.91) and Pharmacology & Therapeutics (IF 9.40), demonstrating translational research from experimental models to clinical cohorts (SAFAS, PARADISE studies).
No scientific awards are currently documented in available sources.
Dr. Meloux leads research within INSERM U1093 CAPS ('Cerebro-Cardiovascular Pathophysiology and Epidemiology'), directing projects on brain-heart interactions during ischemic events. His work involves multidisciplinary collaboration across neurology, cardiology, and physiology departments, utilizing both human clinical data and rat experimental models. Current investigations focus on exercise-induced neuroprotection mechanisms and biomarker validation for stroke prognosis.


